Air Liquide’s subsidiary Schulke, which specialises in hygiene and hospital disinfection products, has acquired Healthcare Antisepsis Solutions (HAS) - the skin disinfection and hygiene business unit for Advanced Sterilization Products, a division of Ethicon Inc.
Healthcare Antisepsis’ hygiene product line offers a broad range of solutions for skin disinfection, particularly in hospital settings, which generated revenue of nearly Euro 40 million in 2014. The products are distributed in numerous countries in the Asia-Pacific region, under the Microshield brand name.
Air Liquide will acquire all of the assets related to the HAS business in this region, which will be progressively transferred to Air Liquide, starting May 2015. In addition to complementing Schulke’s products, this acquisition represents a major geographic development of Air Liquide’s hygiene business activity.
Pascal Vinet, vice president healthcare global operations and member of Air Liquide group’s executive committee, said, “This acquisition is in line with the development strategy for Air Liquide’s hygiene activity. It will allow us to develop our business in Asia, which has significant potential for growth and to gain a foothold in new geographic markets.”
Healthcare Antisepsis’ hygiene product line offers a broad range of solutions for skin disinfection, particularly in hospital settings, which generated revenue of nearly Euro 40 million in 2014. The products are distributed in numerous countries in the Asia-Pacific region, under the Microshield brand name.
Air Liquide will acquire all of the assets related to the HAS business in this region, which will be progressively transferred to Air Liquide, starting May 2015. In addition to complementing Schulke’s products, this acquisition represents a major geographic development of Air Liquide’s hygiene business activity.
Pascal Vinet, vice president healthcare global operations and member of Air Liquide group’s executive committee, said, “This acquisition is in line with the development strategy for Air Liquide’s hygiene activity. It will allow us to develop our business in Asia, which has significant potential for growth and to gain a foothold in new geographic markets.”